Day 1 - Tuesday, 29 May 2018
Meeting category
Date(s)
29 May 2018 - 1 Jun 2018
Location
Kigali,
Rwanda
INTEREST 2018
Related Enduring Materials
Enduring Materials
- 09:00
09:00
Welcome from the Conference Co-chairs
Sabin Nsanzimana, MD, MSc, PhD(c)
Rwanda Biomedical Center, Rwanda
Catherine Hankins, MD, PhD, FRCP, CM
Amsterdam Institute for Global Health and Development, The Netherlands / Canada
Elly Katabira, MD, FRCP
Makerere University College of Health Sciences, Uganda
Official Opening Session -
Chairs
Elly Katabira, MD, FRCP
Makerere University College of Health Sciences, Uganda
Sabin Nsanzimana, MD, MSc, PhD(c)
Rwanda Biomedical Center, Rwanda
09:10
Welcome to Kigali
Mayor of the City of Kigali
Rwanda
09:25
Welcome to Rwanda
Honourable Minister of Health - Diane Gashumba, MD, MMed
Rwanda
Session I: Susceptibility to HIV and novel HIV prevention technologies -
Chairs
Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD, MBE
Kenya Medical Research Institute, Kenya
François Venter, MBCCH, MMed, FCP, DTM&H
University of the Witwatersrand, South Africa
11:00
HIV risk in young women: vaginal microbiome, inflammatory cytokines, and structural and behavioural determinants
Heather Jaspan, MD, PhD
Seattle Children’s Research Institute / University of Cape Town, USA / South Africa
11:50
Novel HIV prevention methods for women
Oral Abstract presentations I: -
Chairs
Anna Laura Ross, PhD
Unitaid, Geneva, Switzerland
Sam Phiri, DCM, MSc, PhD
University of North Carolina School of Medicine, Chapel Hill, USA
13:30
Facility-based HIV self-testing for outpatients dramatically increases HIV testing in Malawi: a cluster randomized trial
Frackson Nuka Shaba, Malawi
#1
13:45
Equity not equality of services: Case of HIV Differentiated Service Delivery Model (DSDM) in Rwanda
14:00
PrEP uptake among pregnant and postpartum women: results from a large implementation program within routine maternal child health (MCH) clinics in Kenya
John Kinuthia, Kenya
#3
14:15
Leave no stone unturned: multiple structural response for KP programming in Swaziland
Session II: Implications for HIV prevention and treatment of projected demographic shifts in Africa -
Chair
Catherine Hankins, MD, PhD, FRCPC, CM
University of Amsterdam; McGill University; London School of Hygiene and Tropical Medicine
Symposium I: IAS: Comprehensive service delivery for key populations -
James Hakim, MBChB, MMed, FRCP, FCP, DSc(HC)
Chair
James Hakim, MBChB, MMed, FRCP, FCP, DSc(HC)
Zimbabwe
15:45
Opening and introduction
University of Zimbabwe College of Health Sciences (UZCHS), Zimbabwe
15:45
HIV and HCV in key populations: Epidemiology and normative guidance
Nathan Ford, MPH, PhD, FRCPE
Switzerland
15:52
Providing clinical services to key populations: Case examples
Providing PrEP and PEP to men who have sex with men in South Africa
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD. South Africa
Addressing the needs of people who inject drugs (including harm reduction as well as HIV and HCV care) in Tanzania
Mwajuma Mussa Mwihumbo, Tanzania
Providing sexual and reproductive health services to female sex workers in Rwanda
Sabin Nsanzimana, MD, MSc, PhD(c). Rwanda
Providing voluntary counselling and testing services to transgender people in Kenya
Wanjiru Mukoma, PhD. Kenya
16:32
Open floor discussion
James Hakim, MBChB, MMed, FRCP, FCP, DSc(HC)
Zimbabwe
16:42
Summary and closing
James Hakim, MBChB, MMed, FRCP, FCP, DSc(HC)
Zimbabwe
Opening Day Formal Debat Resolved: It is the responsibility of research funding organizations and researchers to ensure access, uptake, and adherence to free, onsite oral HIV pre-exposure prophylaxis as the standard of care for all participants at risk fo -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Chair
Peter Kilmarx, MD, FACP, FIDSA
Fogarty International Center NIH, USA
16:57
First Speaker against the proposition
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
17:04
Debate from the floor
17:30
Second Speaker for the proposition
Imelda Mahaka, BSc, MA(c)
Pangaea Global Aids Foundation, Zimbabwe
17:34
Second Speaker against the proposition
Jacqueline Wambui Mwangi
AfroCAB, Kenya
17:38
Rebuttal (each first speaker 2 minutes)
Day 1 -Wednesday, 30 May 2018
- 07.00
07.00
Parallel early morning sessions: grantspersonship, mentoring, and themed poster discussions
Session III: Update on HIV vaccines and the promise of a cure -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Chairs
Pierre-Marie Girard, MD, PhD
Centre Hospitalier-Universitaire St Antoine, Paris
Guido Ferrari, MD
Duke University, USA
08:00
HIV vaccine pipeline and progress
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
08:30
HIV cure: current status and implications for the future
Carolyn Williamson, PhD
University of Cape Town / National Health Laboratory Service, South Africa
Mini-Oral Abstract presentations I -
Chairs
Helen Rees, MD, MA, MRCGP
Wits Reproductive Health and HIV Institute, South Africa
Chewe Luo, MD, PhD
UNICEF, USA
09:00
Delivering a high-quality comprehensive package of HIV prevention, care, and treatment for key populations is possible: Experience from two years of the FHI 360 LINKAGES Malawi project
Gift Kamanga, Malawi
#9
09:06
Clients of Female Sex Workers: Recruitment and HIV prevalence in Rwanda
Alaxandra Hoagland, Rwanda
#10
09:12
Post-Exposure Prophylaxis and Ongoing HIV Risk in Rwanda: Potential for PEP-to-PrEP Transition Programs
Lisa A. Mills, Uganda
#11
09:18
Who wants PrEP? Baseline characteristics of clients initiating PrEP when offered to the general population in Swaziland
Anita Hettema, Swaziland
#12
09:24
Rwanda’s Reduction of HIV Vulnerability Among Women through Integrating Female Empowerment Strategy into National, CrossSector Law and Policy
Elise Mutunge, Rwanda
#13
09:30
Partner-delivered HIV self-testing increases the perceived acceptability of index partner testing among HIV-positive clients in Malawi
Ogechukwu Agatha Offorjebe, Malawi
#14
09:36
Increasing Male Partners Involvement in PMTCT Services in Zanzibar, United Republic of Tanzania
Frida Godfrey, Tanzania
#15
09:42
HIV treatment outcomes among female sex workers and men who have sex with men in Cameroon Potential for PEP-to-PrEP Transition Programs
Anna Bowring, Cameroon
#16
09:48
The Sex Worker Virtual Currency: Incentivizing Peer Educators to Expand Peer Mobilization among Female Sex Workers in Kisumu County, Kenya
Wycliff Odera, Kenya
#17
09:54
Characterizing the Influence of Structural Determinants of Risk on Consistent Condom Use among female sex workers in Senegal
Jean Olivier Twahirwa Rwema, Rwanda
#18
Symposium II: Gilead: The Next Era of HIV & Comorbidities: Ageing and Going Beyond HIV Disease Management -
Chairs
Andrew Kambugu, MB.ChB, MMed, FRCP
Makerere University, Kampala, Uganda
10:30
Symposium Introduction: Objective and Goals
10:35
Epidemiology: Overview of HIV and Ageing: Focus on the female patient: Renal and Bone effect
Mas Chaponda, MBBS, PhD, FRCP & DipHIV
United Kingdom
10:50
Interactive Session: Case Study
11:10
Focus on other comorbidities and Drug-Drug Interactions with HAART
Mas Chaponda, MBBS, PhD, FRCP & DipHIV
United Kingdom
11:20
Interactive Session: Case Study
Mas Chaponda, MBBS, PhD, FRCP & DipHIV
United Kingdom
11:35
Overview of HIV and ageing in Africa: Uganda experience
11:45
Multi drug effects, traditional factors and herbal inclusion: Interactive Case Study: Ageing African patient – Comorbidities and HAART
Symposium III: Johnson & Johnson: Optimizing Treatment Outcomes for Youths Living with HIV in Sub-Saharan Africa -
Chair
Victor Musiime, MBChB, MMed, PhD
Uganda
13:30
Welcome and Introduction
13:35
Clinical perspectives – experiences and challenges in care for youths living with HIV
Muhayimpundu Ribakare, MD, MSc
Rwanda
13:50
Fresh perspectives – the youth experience of living with HIV
Maitia Matee
Lesotho
14:05
Nothing for us, without us! Providing holistic youth-responsive HIV care in resource-limited settings
Elona Toska, MD
South Africa
14:20
Bridging perspectives – how youth insights can be used to optimize treatment outcomes
Session IIII: Factors influencing progress towards 90-90-90 across Africa -
Chair
Linda-Gail Bekker, MBCHB, DTMH, DCH, FCP(SA), PhD
University of Cape Town (UCT), South Africa
Serge Eholié
Cote d’Ivoire
16:20
Improving access to and utilization of viral load testing for better patient management
16:45
Panel discussion, audience Q&A, and general discussion
Mini-Oral Abstract presentations II -
Chairs
Stephen Watiti
Uganda
Sabine Hermans
The Netherlands
17:00
Trends in HIV prevalence among adolescents and adults accessing HIV testing services in four regions in Kenya between 2012 and 2017
Julie Ambia, Kenya
#19
17:06
Adolescent HIV services: Implementing universal antiretroviral treatment for 10-19 year olds living with HIV in eight African countries
Thabiso Lekhotsa, Lesotho
#20
17:12
Reaching 90-90-90 targets amongst adolescents and young people in South Africa: A model of integrated adolescent care
Catherine Martin, South Africa
#21
17:18
Differentiated Service Delivery to HIV infected children and young adults in rural Zimbabwe - a role for near point-of-care diagnostic testing
Vinie Kwoyang Kouamou, Zimbabwe
#22
17:24
Progress Towards the 90-90-90 Targets among HIV-infected Pregnant Mothers: Experience from Uganda
Simon Muhumuza, Uganda
#23
Day 3 - Thursday, 31 May 2018
- 07:00
07:00
Parallel early morning sessions: grantspersonship, mentoring, and themed poster discussions
Session V: Co-infections -
Chairs
Kumar Kumarasamy
India
Frank Cobelens
The Netherlands
Symposium IV: AbbVie: The Role of Clinical Mentorship in improving Standards of HIV Care in Resource-Limited Settings -
Lloyd Mulenga, BScHB, MBChB, MSc, MMed, PhD
Chair
Albert Mwango , BScHB, MBChB, MPH
Zambia
09:30
Opening remarks & Introduction of Speakers
Albert Mwango, BScHB, MBChB, MPH
Zambia
09:35
Perspective from Zambia
Ministry of Health / University Teaching Hospital, Zambia
09:50
Perspective from Kenya
Maureen Kimani, BScHB, MBChB, MSc
Kenya
10:05
Perspective from Nigeria
Joseph Enegela, MBBS, PGDGID, FRSPH, AAHIVS, PMDPro2
Nigeria
10:20
Discussion & Closing
Albert Mwango, BScHB, MBChB, MPH
Zambia
Symposium V: GSK/ViiV: Holistic HIV Management: Putting patients first when selecting an ideal treatment -
Chair
Sibongile Kubheka
South Africa
11:00
Welcome and Introduction
Sibongile Kubheka, MD, MPharmMed
South Africa
11:05
HIV Treatment Expectations: Efficacy, Tolerability, Resistance, Safety, Convenience
Sibongile Kubheka, MD, MPharmMed
South Africa
11:20
HIV/TB Coinfection and DTG in Second Line Treatment: INSPIRING and DAWNING Studies
Corklin Steinhart, MD, PhD
USA
11:50
Prevalence of HLA B5701 in a Kenyan population with HIV infection
Reena Shah, MBBS, MRCP, MScID, FRCPE
Kenya
Mini-Oral Abstract presentations III -
Chairs
Andrew Kambugu
Ugand
Godelieve de Bree
The Netherlands
13:30
Incidence and progression of echocardiographic abnormalities in HIV-infected older children and adolescents taking antiretroviral therapy: A prospective
Edith Majonga, United Kingdom
#24
13:36
Gender-related roles and behaviours impact on adherence to antiretroviral among HIV+ youth
Charles Ingabire, Rwanda
#25
13:42
Long term outcome of first-line antiretroviral treatment among HIV infected children in Uganda
Minke Huibers, The Netherlands
#26
13:48
Pregnancy outcomes in women on contraceptives and established antiretroviral therapy in Malaw
Wongani Nyangulu, Malawi
#27
13:54
Prevalence and correlates of depression among HIV positive patients on Highly Active Antiretroviral Therapy at a Kenyan referral hospital
George Mugendi, Kenya
#28
Session VI: Mentoring the next generation of African scientists -
Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD, PGD (Research Ethics), MBE (Bioethics), CIP
Chairs
Jeanne Kagwiza
Rwanda
Roger Glass
USA
14:05
Presentation
14:13
Presentation
Kenya Medical Research Institute, Kenya
Oral Abstract presentations II -
Chairs
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD. South Africa
South Africa
James Hakim, MBChB, MMed, FRCP, FCP, DSc(HC)
Zimbabwe
15:30
Pilot implementation of point of care early infant hiv diagnosis in Kenya
15:45
A cross-country unit cost analysis of community-based HIV selftest kit distribution in Malawi, Zambia and Zimbabwe
16:00
Secondary distribution of HIV self-tests as a way to promote HIV testing among male partners of young women: subgroup analysis from a randomized trial
16:15
School health nursing programme for adolescents
Overview
Welcome
The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.
We would like to thank all of the 592 participants of the 12th INTEREST Conference (29 May - 1 June 2018, Kigali, Rwanda) for their invaluable contribution in making this meeting such a success. We would also like to dedicate our gratitude to our sponsors, ViiV/GSK, Johnson & Johnson, Gilead, AbbVie, Roche, Mylan, NIH/Fogarty, Joep Lange Institute, IAS, ANRS and BD, for their generous support that made this event possible.
INTEREST is co-organised by Amsterdam Institute for Global Health and Development (AIGHD) and Virology Education.
Official Conference Website
Language
Related Programs
